Tag Archives: radiopharmaceuticals
Toward more accessible PET imaging: Miniaturizing the last step of radiotracer preparation
Positron emission tomography (PET) is a 3D body imaging method for visualizing dynamic biochemical processes in living subjects with unparalleled specificity and sensitivity. PET scans, often performed together with CT or MRI imaging, are used clinically to
Lutetium-177 radioisotope targeted therapy for treatment of cancer and other diseases
By their nature, radioactive isotopes are unstable and can change to more stable forms by radioactive decay and emission of different types of radiation. This emitted radiation is useful for cancer treatment which includes placement of “sealed”
A novel 18F-azido click agent and their applications in PET imaging
Positron-emission tomography (PET) is a non-invasive molecular imaging technique that is used to study and visualize in vivo physiology by the detection of positron-emitting (radiolabeled) compounds. Fluorine-18, represented by symbol 18F, is the most widely used element
